<table id="fdbf8efe-277a-4bd0-8554-c473213279b4" width="630" xmlns="urn:hl7-org:v3" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
<caption>Table 5 Mean Change in Drug Exposure (AUC<sub>0-∞</sub> and C<sub>max</sub>) when Administered with WELCHOL (3.75 g)<sup>a</sup>
</caption>
<tfoot>
<tr>
<td colspan="6">
<sup>a</sup> With verapamil, the dose of WELCHOL was 4.5 g</td>
</tr>
<tr>
<td colspan="6">
<sup>b</sup> Should be administered at least 4 hours prior to WELCHOL. <content stylecode="italics">[See Drug Interactions <linkhtml href="#FD74C20F-636E-4E71-AEE6-3097E4C766E3">(7)</linkhtml>]</content>
</td>
</tr>
<tr>
<td colspan="6">* Oral contraceptive containing norethindrone and ethinyl estradiol.</td>
</tr>
<tr>
<td colspan="6">N/A — Not Available</td>
</tr>
</tfoot>
<tbody>
<tr>
<th align="left">
<br/>
<br/>
<br/>
<br/>Drug</th>
<th align="center">
<br/>
<br/>
<br/>
<br/>Dose</th>
<th align="center" colspan="2" stylecode="botrule">
<br/>
<br/>Co-administered</th>
<th align="center" colspan="2" stylecode="botrule">
<br/>
<br/>
<br/>1 hr prior to<br/>WELCHOL</th>
<th align="center" colspan="2" stylecode="botrule">
<br/>
<br/>
<br/>4 hr prior to<br/>WELCHOL</th>
</tr>
<tr stylecode="botrule">
<td></td>
<td></td>
<td align="center" colspan="2">AUC0-∞ Cmax</td>
<td align="center" colspan="2">AUC0-∞ Cmax</td>
<td align="center" colspan="2">AUC0-∞ Cmax</td>
</tr>
<tr>
<td align="left">Verapamil sustained-release</td>
<td align="center">240 mg</td>
<td align="center">-31%</td>
<td align="center">-11%</td>
<td align="center">N/A</td>
<td align="center">N/A</td>
<td align="center">N/A</td>
<td align="center">N/A</td>
</tr>
<tr>
<td align="left">Glyburide<sup>b</sup>
</td>
<td align="center">3 mg</td>
<td align="center">-32%</td>
<td align="center">-47%</td>
<td align="center">-20%</td>
<td align="center">-15%</td>
<td align="center">-7%</td>
<td align="center">4%</td>
</tr>
<tr>
<td align="left">Levothyroxine<sup>b</sup>
</td>
<td align="center">600 µg</td>
<td align="center">-22%</td>
<td align="center">-33%</td>
<td align="center">6%</td>
<td align="center">-2%</td>
<td align="center">1%</td>
<td align="center">8%</td>
</tr>
<tr>
<td align="left">Norethindrone*<sup>b</sup>
</td>
<td align="center">1 mg</td>
<td align="center">-1%</td>
<td align="center">-20%</td>
<td align="center">5%</td>
<td align="center">-3%</td>
<td align="center">6%</td>
<td align="center">7%</td>
</tr>
<tr>
<td align="left">Ethinyl Estradiol*<sup>b</sup>
</td>
<td align="center">0.035 mg</td>
<td align="center">-24%</td>
<td align="center">-24%</td>
<td align="center">-18%</td>
<td align="center">-1%</td>
<td align="center">-12%</td>
<td align="center">0%</td>
</tr>
<tr>
<td align="left">Repaglinide</td>
<td align="center">2 mg</td>
<td align="center">-7%</td>
<td align="center">-19%</td>
<td align="center">-6%</td>
<td align="center">-1%</td>
<td align="center">N/A</td>
<td align="center">N/A</td>
</tr>
<tr>
<td align="left">Cyclosporine
													</td>
<td align="center">200 mg</td>
<td align="center">-34%</td>
<td align="center">-44%</td>
<td align="center">N/A</td>
<td align="center">N/A</td>
<td align="center">N/A</td>
<td align="center">N/A</td>
</tr>
</tbody>
</table>